§ BIOTECHNOLOGY
USD · Biotechnology

AMRN

AMARIN CORP PLC -ADR
USDSector · Biotechnology
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Sarissa Capital Management LP1.7M15.3%±0%
Kynam Capital Management, LP472K0.4%+21%
Point72301K0.0%+81%
Morgan Stanley IM271K0.0%−56%
ARK Invest241K0.0%+560%
Waterfront Wealth Inc.203K0.5%+43%
AC INTELLIGENCE

Top institutional owners for AMRN as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER98.9% · 0 holders
OTHER0.9% · 46 holders
DEALER / BANK0.1% · 11 holders
TACTICAL / MACRO0.1% · 2 holders
SYSTEMATIC / QUANT0.0% · 3 holders
INCOME / DEFENSIVE0.0% · 4 holders
QUALITY / COMPOUNDER0.0% · 1 holder
PASSIVE / INDEX0.0% · 3 holders
AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
AC INTELLIGENCE

No Form 4 filings on record for AMRN in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention AMRN yet.